EBOS Group stock heads toward its October 21 annual meeting

Published on 10/08/2026 at 02:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EBOS Group stock was trading at NZD 19.04 on October 8, 2026, up 0.69 percent on NZX. Its annual meeting is set for October 21, while FY2026 revenue rose 9.9 percent.

EBO, NZEBOE0001S6, Illustration mit AI erstellt.

EBOS Group stock (ISIN NZEBOE0001S6) was trading at NZD 19.04 on the NZX on October 8, 2026, up 0.69 percent from the prior close. The company is heading toward its annual meeting on October 21, 2026, according to Finscry.

Annual meeting sets the next date

The meeting will be held as a hybrid event in Auckland and online, giving shareholders a scheduled checkpoint after the company completed its FY 2026 reporting cycle. The event is the clearest near-term corporate date for the New Zealand-listed healthcare distributor.

The notice was lodged under the EBO code on September 17, 2026, according to NZX. EBOS Group operates across healthcare, medical and pharmaceutical distribution and also markets animal care brands.

FY 2026 growth meets investment cycle

EBOS Group entered FY 2027 after revenue increased 9.9 percent to AUD 13.5 billion in FY 2026. Underlying EBITDA rose 5 percent to AUD 614 million, according to the companys earnings call transcript published by Yahoo Finance.

The comparison matters because the result came while EBOS completed a multi-year AUD 360 million distribution center renewal program. Management said FY 2027 capital expenditure should normalize to AUD 100 million, compared with AUD 145 million in FY 2026, potentially shifting the financial narrative from construction spending toward utilization and cash generation.

The same transcript showed different growth rates across the portfolio. Healthcare revenue rose 8.5 percent to AUD 12.6 billion, while Animal Care revenue increased 34.6 percent to AUD 907 million. That mix gives the annual meeting a practical investor question: how quickly can the faster-growing divisions offset competitive pressure in community pharmacy?

Stock remains below its yearly high

At NZD 19.04, the stock was 36.5 percent below its 52-week high of NZD 29.95 and above the 52-week low of NZD 18.45 on October 8, 2026. Market capitalization stood at NZD 3.9 billion, while volume reached 99,494 shares during the session.

For investors, the October 21 meeting provides the next dated test of the companys shift from major infrastructure investment to operating productivity. EBOS Group stock combines that scheduled corporate event with FY 2026 revenue growth and a lower planned capital expenditure base.